OBJECTIVE
To determine if there is significant symptomatology in women with heterozygous alpha-galactosidase mutations.
METHODS
Data from medical records of the 44 heterozygous females followed at Cedars-Sinai Medical Center were compiled and analyzed for symptoms of Fabry disease. Quality of life